Zydus Lifesciences Drug Patent Portfolio

Zydus Lifesciences owns 1 orange book drug protected by 1 US patent Given below is the list of Zydus Lifesciences's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10925871 Pharmaceutical compositions of sitagliptin 25 Feb, 2035
Active


Given below is the list of recent legal activities going on the following drug patents of Zydus Lifesciences.

Activity Date Patent Number
Patent litigations
Recordation of Patent Grant Mailed 23 Feb, 2021 US10925871
Patent Issue Date Used in PTA Calculation 23 Feb, 2021 US10925871
Email Notification 04 Feb, 2021 US10925871
Issue Notification Mailed 03 Feb, 2021 US10925871
Dispatch to FDC 25 Jan, 2021 US10925871
Dispatch to FDC 22 Jan, 2021 US10925871
Issue Fee Payment Verified 19 Jan, 2021 US10925871
Application Is Considered Ready for Issue 19 Jan, 2021 US10925871
Issue Fee Payment Received 19 Jan, 2021 US10925871
Issue Fee Payment Verified 18 Jan, 2021 US10925871
Mail Response to 312 Amendment (PTO-271) 30 Dec, 2020 US10925871
Email Notification 30 Dec, 2020 US10925871
Response to Amendment under Rule 312 23 Dec, 2020 US10925871
Amendment after Notice of Allowance (Rule 312) 21 Dec, 2020 US10925871
Mail PUB other miscellaneous communication to applicant 19 Nov, 2020 US10925871


Zydus Lifesciences's Family Patents


Family Patents



Zydus Lifesciences Drug List

Given below is the complete list of Zydus Lifesciences's drugs and the patents protecting them.


1. Zituvio

Zituvio is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10925871 Pharmaceutical compositions of sitagliptin 25 Feb, 2035
(10 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zituvio's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List